 Novartis AG NYSE: NVS has reported a core EPS of 1.56 in Q2 FY22 compared to 1.66 a year ago, beating the consensus of 1.52. Net sales were 12.78 billion, down 1 YY or up 5 at constant currency CC, missing the consensus of 13.01 billion. 